SCHEMBL6560565

SCHEMBL6560565

O[C@H](C[C@@H]1CCCCN1)c1ccc(Br)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.56
FDPS P14324 1/20 0.43
MEN1 O00255 2/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 1/20 0.42
MLNR O43193 1/20 0.42
ABCB11 O95342 1/20 0.42
EGFR P00533 1/20 0.42
FYN P06241 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
HTR1A P08908 1/20 0.42
CHRM5 P08912 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
CHRM1 P11229 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5949168 1.00 CYP2D6 (0.56) CYP2D6FDPSMEN1LMNATP53
SCHEMBL6560568 1.00 CYP2D6 (0.56) CYP2D6FDPSMEN1LMNATP53
SCHEMBL10679403 0.84 CYP2D6 (0.62) CYP2D6CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL5949272 0.81 CYP2D6 (0.53) CYP2D6FDPSMEN1LMNATP53
SCHEMBL465920 0.80 CYP2D6 (0.58) CYP2D6CYP1A2SLC6A2SLC6A4SLC6A3
SCHEMBL20833013 0.80 CYP2D6 (0.56) CYP2D6LMNACYP1A2TSHRSLC6A2
SCHEMBL22259900 0.80 CYP2D6 (0.56) CYP2D6LMNACYP1A2TSHRSLC6A2
SCHEMBL20832991 0.80 CYP2D6 (0.56) CYP2D6LMNACYP1A2TSHRSLC6A2
SCHEMBL8507267 0.80 CYP2D6 (0.56) CYP2D6LMNACYP1A2TSHRSLC6A2
SCHEMBL11536391 0.79 HSD17B10 (0.61) CYP2D6FDPSMEN1LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1050531-B1 Pyridine and piperidine derivatives for treating neurodegenerative diseases SERVIER LAB (FR) 2004-11-17 EP disclosed
EP-1050531-A1 Pyridine and piperidine derivatives for treating neurodegenerative diseases ADIR ET COMPAGNIE (FR) 2000-11-08 EP disclosed